Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00177086
Status:
COMPLETED
Last Update Posted:
2013-03-18
First Post:
2005-09-13
Brief Title:
Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi
Sponsor:
University of Minnesota
Organization:
University of Minnesota
Study Overview
Official Title:
Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi
Status:
COMPLETED
Status Verified Date:
2013-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will assess improvement in the percentage of spontaneous stone passage for distal ureteral calculi for alfuzosin compared to placebo decrease of pain and narcoticanalgesic use associated with stone passage decrease of the time to spontaneous stone passage shift in the size distribution of stones passed towards larger sizes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 3579B | None | None | None |
| L9839 | None | None | None |